West Pharmaceutical Servs (NYSE:WST) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
If history is any guide, there may be trouble ahead for shares of West Pharmaceutical Servs (NYSE:WST). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
West Pharmaceutical Servs (NYSE:WST) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.91 by 6.81 percent. This is a 52.24 percent increase over earnings of $1.34 per share
Companies Reporting Before The Bell
• Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.
Exclusive long-term supply and development agreement includes a multimillion-dollar capital and R&D investment in Corning to enable advanced drug containment and delivery system solutions
EXTON, Pa., Jan. 25, 2022